Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in Mediators Inflamm

Retrieve available abstracts of 15 articles:
HTML format

Single Articles

    January 2021
  1. YOSHIMURA T, Mitsuyama K, Sakemi R, Takedatsu H, et al
    Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
    Mediators Inflamm. 2021;2021:8825374.
    PubMed     Abstract available

  2. ARAFAT EA, Marzouk RE, Mostafa SA, Hamed WHE, et al
    Identification of the Molecular Basis of Nanocurcumin-Induced Telocyte Preservation within the Colon of Ulcerative Colitis Rat Model.
    Mediators Inflamm. 2021;2021:7534601.
    PubMed     Abstract available

  3. GIUDICI F, Cavalli T, Luceri C, Russo E, et al
    Long-Term Follow-Up, Association between CARD15/NOD2 Polymorphisms, and Clinical Disease Behavior in Crohn's Disease Surgical Patients.
    Mediators Inflamm. 2021;2021:8854916.
    PubMed     Abstract available

    January 2020
  4. SAMARANI S, Sagala P, Jantchou P, Grimard G, et al
    Phenotypic and Functional Changes in Peripheral Blood Natural Killer Cells in Crohn Disease Patients.
    Mediators Inflamm. 2020;2020:6401969.
    PubMed     Abstract available

  5. RODRIGUEZ-CANALES M, Martinez-Galero E, Nava-Torres AD, Sanchez-Torres LE, et al
    Anti-Inflammatory and Antioxidant Activities of the Methanolic Extract of Cyrtocarpa procera Bark Reduces the Severity of Ulcerative Colitis in a Chemically Induced Colitis Model.
    Mediators Inflamm. 2020;2020:5062506.
    PubMed     Abstract available

  6. CAMARILLO GF, Goyon EI, Zuniga RB, Salas LAS, et al
    Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis.
    Mediators Inflamm. 2020;2020:9238970.
    PubMed     Abstract available

  7. DING X, Bin P, Wu W, Chang Y, et al
    Tryptophan Metabolism, Regulatory T Cells, and Inflammatory Bowel Disease: A Mini Review.
    Mediators Inflamm. 2020;2020:9706140.
    PubMed     Abstract available

  8. SHAO X, Yang L, Hu K, Shen R, et al
    Serum Cholinesterases, a Novel Marker of Clinical Activity in Inflammatory Bowel Disease: A Retrospective Case-Control Study.
    Mediators Inflamm. 2020;2020:4694090.
    PubMed     Abstract available

  9. HA J, Oh H, Oh NS, Seo Y, et al
    Anti-Inflammatory Effect of a Peptide Derived from the Synbiotics, Fermented Cudrania tricuspidata with Lactobacillus gasseri, on Inflammatory Bowel Disease.
    Mediators Inflamm. 2020;2020:3572809.
    PubMed     Abstract available

  10. ZHU L, Li Y, Zhou L, Yang G, et al
    Role of RING-Type E3 Ubiquitin Ligases in Inflammatory Signalling and Inflammatory Bowel Disease.
    Mediators Inflamm. 2020;2020:5310180.
    PubMed     Abstract available

  11. XIN Z, Zhai Z, Long H, Zhang F, et al
    Metabolic Profiling by UPLC-Orbitrap-MS/MS of Liver from C57BL/6 Mice with DSS-Induced Inflammatory Bowel Disease.
    Mediators Inflamm. 2020;2020:6020247.
    PubMed     Abstract available

  12. LIN J, Li G, Xu C, Lu H, et al
    Monocyte Chemotactic Protein 1-Induced Protein 1 Is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities.
    Mediators Inflamm. 2020;2020:8812020.
    PubMed     Abstract available

    January 2019
  13. MA C, Vasu R, Zhang H
    The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease.
    Mediators Inflamm. 2019;2019:8495913.
    PubMed     Abstract available

  14. SHU W, Pang Z, Xu C, Lin J, et al
    Anti-TNF-alpha Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease.
    Mediators Inflamm. 2019;2019:4038619.
    PubMed     Abstract available

  15. KANG J, Zhang Z, Wang J, Wang G, et al
    hucMSCs Attenuate IBD through Releasing miR148b-5p to Inhibit the Expression of 15-lox-1 in Macrophages.
    Mediators Inflamm. 2019;2019:6953963.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.